New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Role of Stem Cell Transplantation Evolving in Multiple Myeloma

Role of Stem Cell Transplantation Evolving in Multiple Myeloma

March 11, 2015Laura PanjwaniOncLive interviewed Ravi Vij, MD, associate professor, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine and the Sitema
World medicine November 21,2023
Role of Stem Cell Transplantation Evolving in Multiple Myeloma

Role of Stem Cell Transplantation Evolving in Multiple Myeloma

March 11, 2015Laura PanjwaniOncLive interviewed Ravi Vij, MD, associate professor, Division of Oncology, Section of Bone Marrow Transplantation, Washington University School of Medicine and the Sitema
World medicine November 21,2023
Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

May 18, 2016Laura PanjwaniEarly findings from a phase III clinical trial suggest that patients with multiple myeloma who receive upfront autologous stem cell transplant survive longer without disease
World medicine November 21,2023
Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

Stem Cell Transplant Continues to Show Benefit in 'Novel-Agent Era' of Multiple Myeloma

May 18, 2016Laura PanjwaniEarly findings from a phase III clinical trial suggest that patients with multiple myeloma who receive upfront autologous stem cell transplant survive longer without disease
World medicine November 21,2023
Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma

Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma

December 8, 2014Silas InmanPatients with HIV-associated lymphoma can effectively be treated with autologous hematopoietic stem cell transplantation, with outcomes that are similar to patients without
World medicine November 21,2023
Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma

Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma

December 8, 2014Silas InmanPatients with HIV-associated lymphoma can effectively be treated with autologous hematopoietic stem cell transplantation, with outcomes that are similar to patients without
World medicine November 21,2023
Stem Cell Transplantation May Impair Sexual Health

Stem Cell Transplantation May Impair Sexual Health

December 3, 2013Jill SteinBoth men and women report a significant decline in sexual satisfaction after hematopoietic cell transplantation that is sustained at 3-year follow-up.F. Lennie Wong, PhDBoth
World medicine November 21,2023
Stem Cell Transplantation May Impair Sexual Health

Stem Cell Transplantation May Impair Sexual Health

December 3, 2013Jill SteinBoth men and women report a significant decline in sexual satisfaction after hematopoietic cell transplantation that is sustained at 3-year follow-up.F. Lennie Wong, PhDBoth
World medicine November 21,2023
Stem Cell Transplant Techniques Evolving to Include More Patient Populations

Stem Cell Transplant Techniques Evolving to Include More Patient Populations

June 20, 2017Gina ColumbusTsiporah B. Shore, MD, discusses some of these newer advancements related to stem cell transplantation and the challenges with including patients in ethnic populations.Tsipor
World medicine November 21,2023
Stem Cell Transplant Techniques Evolving to Include More Patient Populations

Stem Cell Transplant Techniques Evolving to Include More Patient Populations

June 20, 2017Gina ColumbusTsiporah B. Shore, MD, discusses some of these newer advancements related to stem cell transplantation and the challenges with including patients in ethnic populations.Tsipor
World medicine November 21,2023
Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

August 8, 2018Caroline SeymourNoa Biran, MD, discusses patient-reported outcomes following autologous stem cell transplant in patients with myeloma.Noa Biran, MDPreliminary pilot data presented at the
World medicine November 21,2023
Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

Patient-Reported Outcomes With Stem Cell Transplant Signal Progress in Myeloma

August 8, 2018Caroline SeymourNoa Biran, MD, discusses patient-reported outcomes following autologous stem cell transplant in patients with myeloma.Noa Biran, MDPreliminary pilot data presented at the
World medicine November 21,2023
Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma

Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma

August 31, 2012Jill SteinLenalidomide used continuously after autologous hematopoietic stem cell transplantation significantly prolonged the time to disease progression and overall survival in patient
World medicine November 21,2023
Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma

Lenalidomide Maintenance After Stem-Cell Transplantation Benefits Patients With Multiple Myeloma

August 31, 2012Jill SteinLenalidomide used continuously after autologous hematopoietic stem cell transplantation significantly prolonged the time to disease progression and overall survival in patient
World medicine November 21,2023
Stem-Cell Transplant Benefit Limited for Double-Hit Lymphoma Patients in Remission

Stem-Cell Transplant Benefit Limited for Double-Hit Lymphoma Patients in Remission

May 22, 2017Angelica WelchDaniel J. Landsburg, MD, discusses the management of patients with double-hit lymphoma who have achieved remission.Daniel J. Landsburg, MDFor patients with double-hit lymphom
World medicine November 21,2023
Stem-Cell Transplant Benefit Limited for Double-Hit Lymphoma Patients in Remission

Stem-Cell Transplant Benefit Limited for Double-Hit Lymphoma Patients in Remission

May 22, 2017Angelica WelchDaniel J. Landsburg, MD, discusses the management of patients with double-hit lymphoma who have achieved remission.Daniel J. Landsburg, MDFor patients with double-hit lymphom
World medicine November 21,2023
Stem Cell Research Aims to Further Personalize Lung Cancer Care

Stem Cell Research Aims to Further Personalize Lung Cancer Care

August 8, 2017Gina ColumbusTushar Desai, MD, discusses his research in stem cells and why discovering which cells have the potential to form lung cancer is significant to the treatment paradigm.Tushar
World medicine November 21,2023
Stem Cell Research Aims to Further Personalize Lung Cancer Care

Stem Cell Research Aims to Further Personalize Lung Cancer Care

August 8, 2017Gina ColumbusTushar Desai, MD, discusses his research in stem cells and why discovering which cells have the potential to form lung cancer is significant to the treatment paradigm.Tushar
World medicine November 21,2023
Stem Cells Create a Therapeutic Niche

Stem Cells Create a Therapeutic Niche

October 18, 2014Surabhi Dangi-Garimella, PhDStem cell therapy has gained increasing traction in various therapeutic areas, from cancer to diabetes to ocular regeneration.Stem cell therapy has gained i
World medicine November 21,2023
Stem Cells Create a Therapeutic Niche

Stem Cells Create a Therapeutic Niche

October 18, 2014Surabhi Dangi-Garimella, PhDStem cell therapy has gained increasing traction in various therapeutic areas, from cancer to diabetes to ocular regeneration.Stem cell therapy has gained i
World medicine November 21,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com